The miR-5694/AF9/Snail Axis Provides Metastatic Advantages and a Therapeutic Target in Basal-like Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The miR-5694/AF9/Snail Axis Provides Metastatic Advantages and a Therapeutic Target in Basal-like Breast Cancer

Published:2021-03 Issue:3 Volume:29 Page:1239-1257
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Tian Xin,Yu Hua,Li Dong,Jin Guojiang,Dai Shundong,Gong Pengchao,Kong Cuicui,Wang Xiongjun

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference65 articles.

1. Breast cancer metastasis: markers and models;Weigelt;Nat. Rev. Cancer,2005

2. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

3. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression;Feinberg;Nat. Rev. Genet.,2016

4. Epigenetic Priming in Cancer Initiation;Vicente-Dueñas;Trends Cancer,2018

5. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials;Cheng;Signal Transduct. Target. Ther.,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MLLT6/ATF2 Axis Restrains Breast Cancer Progression by Driving DDIT3/4 Expression;Molecular Cancer Research;2024-05-17

2. Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non–Small Cell Lung Cancer;Clinical Cancer Research;2024-01-23

3. Unveiling the role of GAS41 in cancer progression;Cancer Cell International;2023-10-18

4. AF9 sustains glycolysis in colorectal cancer via H3K9ac‐mediated PCK2 and FBP1 transcription;Clinical and Translational Medicine;2023-08

5. Hub gene of disulfidptosis-related immune checkpoints in breast cancer;Medical Oncology;2023-07-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3